https://www.globenewswire.com/news-release/2020/05/04/2026582/0/en/FDA-Approves-54-Emergency-INDs-for-Leronlimab-Treatment-of-Coronavirus-CytoDyn-Requests-Compassionate-Use-from-FDA-for-COVID-19-Patients-Not-Eligible-for-Participation-in-Two-Ongoi.html